<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Warfarin • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Warfarin • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/warfarin/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/warfarin/" />

<link rel="stylesheet" href="/wiki/style.css" />

  </head>
  <body>
    <div
      class="fixed top-0 w-screen px-4 py-4 md:px-10 bg-slate-200 bg-opacity-90"
    >
    <div class="flex items-center justify-between max-w-6xl mx-auto">
      <a href="/wiki/" title="Home">
        <img src="/wiki/assets/avatar.png" class="w-10 h-10 " />
      </a>

      <nav class="flex space-x-2 uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-slate-600 hover:text-slate-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 rounded hover:bg-slate-600 hover:text-slate-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>
    <div class="mx-auto">

    <div class="flex items-center justify-center max-w-full px-6 mt-32 mb-32">
      <div  class="prose">
<article><h1>Warfarin</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/INR%20goals/">INR goals</a></li>
</ul>
<hr>
<!-- warfarin reversal how -->
<p><strong>Warfarin</strong> is an anticoagulant commonly used in the treatment of atrial fibrillation and venous thromboembolism.  Effects arise from the inhibition of vitamin K recycling, which reduces circulating levels of vitamin K-dependent clotting factors II, VII, IX, and X.  The major risk of therapy is bleeding-associated complications, particularly <strong>intracranial hemorrhage</strong>.</p>
<p>Patients on warfarin with intracranial hemorrhage require urgent <strong>warfarin reversal</strong> to prevent the propagation of hemorrhage; this is accomplished by administering the following:</p>
<ul>
<li>
<p><strong>Prothrombin complex concentrate</strong>, which contains vitamin K-dependent clotting factors and normalizes INR &lt;10 minutes after administration.</p>
</li>
<li>
<p><strong>Intravenous vitamin K</strong>, which results in sustained warfarin reversal but takes 12-24 hours for full effect.  Because of this delayed effect, vitamin K is always used with clotting factor replacement <strong>(Choice D)</strong>.</p>
<p>Fresh frozen plasma is considered the second-line therapy for replacing vitamin K-dependent clotting factors due to the large volume (often &gt;2 L) required and the delay for blood compatibility tests.  Fresh frozen plasma is typically used when prothrombin complex concentrate is unavailable.</p>
<p>Intravenous idarucizumab is a monoclonal antibody used to reverse the anticoagulant dabigatran, a direct thrombin inhibitor.  This patient was on warfarin, not dabigatran; idarucizumab would be ineffective.</p>
</li>
</ul>
</article>
<hr />
<p>Backlinks</p>


<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Hemeonc/" class="peer">Hemeonc</a>
      <div
        role="none"
        class="absolute hidden p-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-stone-100 prose-headings:hidden prose-hr:hidden"
      >
        <h1>Hemeonc</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2>Heme</h2>
<ul>
<li><a href="/wiki/notes/Bleeding%20disorders/">Bleeding disorders</a></li>
<li><a href="/wiki/notes/Anemia/">Anemia</a></li>
<li><a href="/wiki/notes/DVT%20and%20PE/">DVT and PE</a></li>
<li><a href="/wiki/notes/Hemochromatosis/">Hemochromatosis</a></li>
<li><a href="/wiki/notes/Sickle%20cell%20disease/">Sickle cell disease</a></li>
<li><a href="/wiki/notes/warfarin/">warfarin</a></li>
<li><a href="/wiki/notes/heparin%20induced%20thrombocytopenia/">heparin induced thrombocytopenia</a></li>
<li><a href="/wiki/notes/disseminated%20intravascular%20coagulation/">disseminated intravascular coagulation</a></li>
<li><a href="/wiki/notes/TTP/">TTP</a></li>
<li><a href="/wiki/notes/blood%20smear/">blood smear</a></li>
<li><a href="/wiki/notes/polycythemia%20vera/">polycythemia vera</a></li>
<li><a href="/wiki/notes/essential%20thrombocytosis/">essential thrombocytosis</a></li>
<li><a href="/wiki/notes/anemia%20lecture/">anemia lecture</a></li>
<li><a href="/wiki/notes/transfusion%20medicine/">transfusion medicine</a></li>
<li><a href="/wiki/notes/DIC%20vs%20liver%20disease/">DIC vs liver disease</a></li>
<li><a href="/wiki/notes/anticoagulation%20reversal/">anticoagulation reversal</a></li>
</ul>
<h2>Oncology</h2>
<ul>
<li>[[Paget d</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/INR goals/" class="peer">INR Goals</a>
      <div
        role="none"
        class="absolute hidden p-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-stone-100 prose-headings:hidden prose-hr:hidden"
      >
        <h1>INR goals</h1>
<ul>
<li>related: <a href="/wiki/notes/warfarin/">warfarin</a></li>
</ul>
<hr>
<ul>
<li>mechanical aortic valve: 2-3</li>
<li>mechanical mitral valve: 2.5-3.5</li>
<li>mechanical aortic and mitral: 2.5-3.5</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>



</div>
    </div>

    <!-- <hr />
<p>Backlinks</p>


<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Hemeonc/" class="peer">Hemeonc</a>
      <div
        role="none"
        class="absolute hidden p-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-stone-100 prose-headings:hidden prose-hr:hidden"
      >
        <h1>Hemeonc</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2>Heme</h2>
<ul>
<li><a href="/wiki/notes/Bleeding%20disorders/">Bleeding disorders</a></li>
<li><a href="/wiki/notes/Anemia/">Anemia</a></li>
<li><a href="/wiki/notes/DVT%20and%20PE/">DVT and PE</a></li>
<li><a href="/wiki/notes/Hemochromatosis/">Hemochromatosis</a></li>
<li><a href="/wiki/notes/Sickle%20cell%20disease/">Sickle cell disease</a></li>
<li><a href="/wiki/notes/warfarin/">warfarin</a></li>
<li><a href="/wiki/notes/heparin%20induced%20thrombocytopenia/">heparin induced thrombocytopenia</a></li>
<li><a href="/wiki/notes/disseminated%20intravascular%20coagulation/">disseminated intravascular coagulation</a></li>
<li><a href="/wiki/notes/TTP/">TTP</a></li>
<li><a href="/wiki/notes/blood%20smear/">blood smear</a></li>
<li><a href="/wiki/notes/polycythemia%20vera/">polycythemia vera</a></li>
<li><a href="/wiki/notes/essential%20thrombocytosis/">essential thrombocytosis</a></li>
<li><a href="/wiki/notes/anemia%20lecture/">anemia lecture</a></li>
<li><a href="/wiki/notes/transfusion%20medicine/">transfusion medicine</a></li>
<li><a href="/wiki/notes/DIC%20vs%20liver%20disease/">DIC vs liver disease</a></li>
<li><a href="/wiki/notes/anticoagulation%20reversal/">anticoagulation reversal</a></li>
</ul>
<h2>Oncology</h2>
<ul>
<li>[[Paget d</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/INR goals/" class="peer">INR Goals</a>
      <div
        role="none"
        class="absolute hidden p-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-stone-100 prose-headings:hidden prose-hr:hidden"
      >
        <h1>INR goals</h1>
<ul>
<li>related: <a href="/wiki/notes/warfarin/">warfarin</a></li>
</ul>
<hr>
<ul>
<li>mechanical aortic valve: 2-3</li>
<li>mechanical mitral valve: 2.5-3.5</li>
<li>mechanical aortic and mitral: 2.5-3.5</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


 -->

    <footer>
      <div class="max-w-6xl mb-10 text-sm text-center mt-96 ">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
